Aware Super Pty Ltd as trustee of Aware Super Makes New Investment in Solventum Co. (NYSE:SOLV)

Aware Super Pty Ltd as trustee of Aware Super bought a new stake in Solventum Co. (NYSE:SOLV - Free Report) in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor bought 10,873 shares of the company's stock, valued at approximately $718,000.

Other hedge funds and other institutional investors have also modified their holdings of the company. Modus Advisors LLC acquired a new position in shares of Solventum in the 4th quarter valued at $25,000. Stonebridge Financial Group LLC acquired a new position in Solventum in the fourth quarter valued at about $26,000. Crews Bank & Trust purchased a new position in Solventum during the fourth quarter worth about $32,000. Synergy Asset Management LLC acquired a new stake in shares of Solventum during the fourth quarter valued at about $35,000. Finally, Spire Wealth Management purchased a new stake in shares of Solventum in the 4th quarter valued at approximately $37,000.

Analyst Upgrades and Downgrades

SOLV has been the subject of several research reports. Morgan Stanley lifted their target price on shares of Solventum from $73.00 to $80.00 and gave the company an "equal weight" rating in a report on Wednesday, March 5th. Mizuho increased their target price on Solventum from $70.00 to $82.00 and gave the stock a "neutral" rating in a research note on Monday, March 3rd. Piper Sandler boosted their price target on shares of Solventum from $75.00 to $84.00 and gave the stock a "neutral" rating in a research note on Friday, February 28th. The Goldman Sachs Group raised their price objective on shares of Solventum from $63.00 to $71.00 and gave the company a "sell" rating in a research note on Monday, March 3rd. Finally, Wells Fargo & Company upped their target price on shares of Solventum from $73.00 to $75.00 and gave the stock an "equal weight" rating in a research note on Friday, February 28th. One equities research analyst has rated the stock with a sell rating, eight have assigned a hold rating and one has given a buy rating to the company. According to MarketBeat.com, the stock has a consensus rating of "Hold" and an average target price of $79.86.

Solventum Stock Down 2.3 %

Shares of SOLV traded down $1.55 during midday trading on Monday, reaching $64.72. The stock had a trading volume of 91,999 shares, compared to its average volume of 1,317,474. The company has a debt-to-equity ratio of 2.45, a current ratio of 1.15 and a quick ratio of 0.83. The company's fifty day simple moving average is $73.41 and its two-hundred day simple moving average is $71.67. The company has a market cap of $11.20 billion and a price-to-earnings ratio of 23.53. Solventum Co. has a 1-year low of $47.16 and a 1-year high of $85.92.

Solventum Profile

Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration.